3
2
1

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

2025/08/15

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

2025/07/03

On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.

Significant Achievements: Successfully Cultivated Human Heart in Pigs, Bringing New Hope for Organ Transplantation

2025/06/19

Recently, the world's top - tier academic journal Nature featured a major research achievement by Chinese scientists on its front - page headlines. For the first time, a heart containing human cells was cultivated in a pig embryo, and this heart could beat autonomously and survived for 21 days. This groundbreaking progress offers a brand - new solution to the global shortage of organ transplants and marks a new stage in the development of xenogeneic organ cultivation technology.

Bountiful Harvest: A Review of Life Extension Plan Scientific Achievements

2025/02/07

With the rapid development of science and technology, humanity's exploration of life has never ceased. During the 2023-2024 period, we witnessed a series of exciting scientific achievements. These not only made significant progress in fields such as anti-aging, gene editing, organ regeneration, and immunotherapy but also pointed the way for future medical research.

2025-09-12

New Soft Robots Can Independently Inspect and Melt Ice at Minus 50 Degrees Celsius

Zhang Junshi stated that this research offers new ideas for the development of small intelligent robot systems in extreme environments and broadens the application prospects of new materials in fields such as electronic devices and bionic systems.

2025-09-12

Breaking the Bottleneck! Tsinghua Team's New Technology Enables "Non - Destructive Perspective" of Tissues and Organs

In the future, the team will continue to optimize the universality of the technology, expand its application in plant tissues and clinical pathological samples, and promote its integration with cryo - electron microscopy and super - resolution microscopy, providing key support for precision medicine and intelligent diagnosis. This original achievement is injecting new impetus into global life science research.

2025-09-05

A Crucial Step! World's First Successful Gene - Edited Pig Lung Transplant into a Brain - Dead Patient

This achievement not only validates the feasibility of gene - editing technology in xenogeneic lung transplantation but also marks China's shift from a follower to a leader in this field. With further research, xenogeneic lung transplantation may bring new hope to countless patients awaiting organ transplants.

2025-09-05

Global Record! Major Breakthrough in China's Implantable Brain - Computer Interface Technology

Chinese scientists have achieved a major breakthrough in the field of implantable brain - computer interface technology. The Aerospace Information Research Institute of the Chinese Academy of Sciences and the First Affiliated Hospital of Harbin Medical University jointly completed the world's first clinical trial for precise positioning of deep - brain tumor boundaries using an implantable microelectrode array. This technology enables high - precision lesion navigation through microelectrode devices implanted in the brain, marking China's leading position in the international arena of precise neurosurgical treatment.

2025-08-29

Break through the bottleneck! 3D printing + stem cell technology to help nerve regeneration

Spinal cord injury is the "incurable injury" in the global medical community. On August 23, the University of Minnesota team published a major study in "Advanced Medical Materials", which opened a light for this dilemma: using 3D printing technology to build a "smart scaffold" and combined with the neural progenitor cells cultivated by stem cells, it successfully set up a neural pathway in the body of rats with completely broken spinal cord, so that they can restore their walking ability after 12 weeks.

2025-08-21

-196°C Technological Breakthrough: Electrically - Driven Deep - Cryogenic Storage System ushers in a New Era of Biological Sample Storage

The R & D team plans to establish a domestic industrial chain covering storage, transportation, and preparation within three years. This will break the current reliance on imported high - end life - science instruments, accelerate the application of independently developed equipment, and provide strong technological support for the development of China's biotechnology sector.

2025-08-21

New Breakthrough! Milk Transforms into “Living Material” in Seconds, a Novel Biogel is Born

The top - tier international materials journal Matter has published online the groundbreaking research findings of a joint team from Columbia University and the University of Padua. This study is the first to systematically disclose how to utilize bovine - derived extracellular vesicles (EVs) extracted from yogurt whey, a by - product of milk processing, to construct bioactive injectable hydrogels with dynamic cross - linking properties. This innovative technology offers a new paradigm for resolving the dual challenges of “injectability” and “maintenance of biological activity” in the field of tissue engineering.

2025-08-15

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

2025-08-15

Milestone! Scientists Cultivate “Whole - Brain - Level” Organoids, Breaking the Bottleneck in Neurological Disease Research

Researchers from Johns Hopkins University in the United States recently announced the successful cultivation of the world's first “whole - brain” organoid that contains neural tissues from multiple brain regions and preliminary vascular structures. The relevant findings were published in the journal Advanced Science. This groundbreaking research offers a brand - new experimental model for exploring the mechanisms of complex neuropsychiatric diseases like autism and schizophrenia and for drug development.

< 1234...11 >